Клапанная дренажная система Ahmed в хирургии глаукомы
https://doi.org/10.53432/2078-4104-2024-23-1-96-111
Аннотация
Глаукома представляет собой значимую медикосоциальную проблему. Несмотря на большое разнообразие подходов к лечению глаукомы, подавляющее большинство исследователей полагают, что именно хирургическое лечение остается наиболее эффективным способом нормализации уровня внутриглазного давления и сохранения зрительных функций. Трабекулэктомия и имплантация дренажного устройства являются наиболее часто выполняемыми операциями при глаукоме во всем мире. Хотя трабекулэктомия является «золотым стандартом», в настоящее время наблюдается увеличение частоты использования дренажных устройств при глаукоме. Клапанная дренажная система (КДС) Ahmed является одним из наиболее широко используемых в мире дренажных устройств при глаукоме. В настоящем литературном обзоре обсуждаются данные наиболее актуальных исследований по результатам имплантации КДС, возможным осложнениям и способам оптимизации этого вида вмешательства в хирургии глаукомы.
Об авторах
А. Ю. Расческов
ООО «Глазная хирургия Расческов»
Россия
Россия
Расческов А. Ю., к.м.н., главный врач
420000, Казань, ул. Патриса Лумумбы, 28А
И. А. Лоскутов
ГБУЗ МО «Московский областной научно-исследовательский клинический институт имени М.Ф. Владимирского»; Министерство здравоохранения Московской области
Россия
Россия
Лоскутов И. А., д.м.н., заведующий кафедрой офтальмологии и оптометрии; главный внештатный специалист-офтальмолог
129110, Москва, ул. Щепкина, 61/2
143407, Московская область, Красногорск, бульвар Строителей, 1
А. В. Корнеева
Филиал компании с ограниченной ответственностью «Хадасса Медикал Лтд»
Россия
Россия
Корнеева Алина Владимировна, к.м.н., главный врач
121205, Москва, территория ИЦ «Сколково», Большой бульвар, 46, стр. 1.
Список литературы
1. Первичная открытоугольная глаукома. Национальное руководство. Под ред. Е.А. Егорова, А.В. Куроедова. М: ГЭОТАР-Медиа 2023, 1032. https://www.rosmedlib.ru/book/ISBN9785970476611.html.
2. Tham Y.C., Li X., Wong T. Y., Quigley H.A., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmol 2014; 121(11):2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013.
3. European Glaucoma Society Terminology and Guidelines for Glaucoma (5th Edition). Savona, PubliComm, 2020. 169 p. https://doi.org/10.1136/bjophthalmol-2021-egsguidelines.
4. Arikan G, Gunenc U. Ahmed Glaucoma Valve Implantation to Reduce Intraocular Pressure: Updated Perspectives. Clin Ophthalmol 2023; 17:1833-1845. https://doi.org/10.2147/OPTH.S342721.
5. Jeffrey R., SooHoo M.D., Leonard K., Seibold M., et al. Minimally invasive glaucoma surgery: current implants and future innovations. Can J Ophthalmol 2014; 49(6):528–533. https://doi.org/10.1016/j.jcjo.2014.09.002.
6. Brandгo L.M., Grieshaber M.C. Update on minimally invasive glaucoma surgery (MIGS) and new implants. J Ophthalmol 2013; 2013: 705915. https://doi.org/10.1155/2013/705915.
7. Richter G. M., Coleman A.L. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol 2016; 10:189–206. https://doi.org/10.2147/OPTH.S80490.
8. Basic and Clinical Science Course 2022-2023. Section 10. Glaucoma. Ed. A.P. Tanna. San Francisco, AAO, 2022. 319 p.
9. Stephenson M. Tips and techniques for optimizing approved MIGS. EyeWorld Asia-Pacific 2017; 13(3):22-24.
10. Tseng V.L., Coleman A.L., Chang M.Y. Aqueous shunts for glaucoma. Cochrane Database Syst Rev 2017; 7:CD004918. https://doi.org/10.1002/14651858.CD004918.pub3.
11. Patel S., Pasquale L.R. Glaucoma drainage devices: a review of the past, present, and future. Semin Ophthalmol 2010; 25(5–6):265–270. https://doi.org/10.3109/08820538.2010.518840.
12. Vinod K., Gedde S.J., Feuer W.J., Panarelli J.F., et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma 2017; 26 (8):687–693. https://doi.org/10.1097/IJG.0000000000000720.
13. Murphy C., Ogston S., Cobb C., MacEwen C. Recent trends in glaucoma surgery in Scotland, England and Wales. Br J Ophthalmol 2015; 99(3):308–312. https://doi.org/10.1136/bjophthalmol-2013-304465
14. Bron A.M., Mariet A.S., Benzenine E., Arnould L., et al. Trends in operating room-based glaucoma procedures in France from 2005 to 2014: a nationwide study. Br J Ophthalmol 2017; 101(11):1500–1504. https://doi.org/10.1136/bjophthalmol-2016-309946.
15. Arora K.S., Robin A.L., Corcoran K.J., Corcoran S.L., et al. Use of various glaucoma surgeries and procedures in medicare beneficiaries from 1994 to 2012. Ophthalmology 2015; 122(8):1615–1624. https://doi.org/10.1016/j.ophtha.2015.04.015.
16. Gedde S.J., Schiffman J.C., Feuer W.J., Herndon L.W., et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 2012; 153:789–803. https://doi.org/10.1016/j.ajo.2011.10.026.
17. Gedde S.J., Feuer W.J., Shi W., Lim K.S., et al. Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 1 year of followup. Ophthalmology 2018; 125:650–663. https://doi.org/10.1016/j.ophtha.2018.02.003.
18. Gedde S.J., Feuer W.J., Lim K.S., Barton K., et al. Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 3 years of follow-up. Ophthalmology 2020; 127:333–345. https://doi.org/10.1016/j.ophtha.2019.10.002.
19. Gedde S.J., Feuer W.J., Lim K.S., Barton K., et al. Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 5 years of follow-up. Ophthalmology 2022; 129:1344–1356. https://doi.org/10.1016/j.ophtha.2022.07.003.
20. Eksioglu U., Yakin M., Sungur G., Satana B., et al. Short-to long-term results of Ahmed glaucoma valve in the management of elevated intraocular pressure in patients with pediatric uveitis. Can J Ophthalmol 2017; 52(3):295–301. https://doi.org/10.1016/j.jcjo.2016.11.015.
21. Pakravan M., Esfandiari H., Yazdani S., Doozandeh A., et al. Clinical outcomes of Ahmed glaucoma valve implantation in pediatric glaucoma. Eur J Ophthalmol 2019; 29(1):44–51. https://doi.org/10.1177/1120672118761332.
22. Spiess K., Calvo J.P. Outcomes of Ahmed glaucoma valve in paediatric glaucoma following congenital cataract surgery in persistent fetal vasculature. Eur J Ophthalmol 2021; 31(3):1070-1078. https://doi.org/10.1177/1120672120919066.
23. Jacobson A., Bohnsack B.L. Ahmed to Baerveldt glaucoma drainage device exchange in pediatric patients. BMC Ophthalmol 2023; 23(1): 310. https://doi.org/10.1186/s12886-023-03074-1.
24. Rosentreter A., Mellein A.C., Konen W.W., Dietlein T.S. Capsule excision and Ologen implantation for revision after glaucoma drainage device surgery. Graefes Arch Clin Exp Ophthalmol 2010; 248:1319-1324. https://doi.org/10.1007/s00417-010-1385-y.
25. Lai J.S., Poon A.S., Chua J.K., Tham C.C., et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol 2000; 84:718-721. https://doi.org/10.1136/bjo.84.7.718.
26. Coleman A.L., Smyth R.J., Wilson M.R., Tam M. Initial clinical experience with the Ahmed glaucoma valve implant in pediatric patients. Arch Ophthalmol 1997; 115:186-191. https://doi.org/10.1001/archopht.1997.01100150188007.
27. Yang H.K., Park K.H. Clinical outcomes after Ahmed valve implantation in refractory paediatric glaucoma. Eye (Lond) 2009; 23:1427-1435. https://doi.org/10.1038/eye.2008.261.
28. Goulet R.J. 3rd, Phan A.D., Cantor L.B., WuDunn D. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 2008; 115:1141-1147. https://doi.org/10.1016/j.ophtha.2007.10.034.
29. HaiBo T., Xin K., ShiHeng L., Lin L. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis. PLoS One 2015; 10: e0118142. https://doi.org/10.1371/journal.pone.0118142.
30. Инструкция по применению медицинского изделия клапана глаукоматозного Ахмед модели FP7, FP8. http://ahmedglaucoma.ru/index.php?option=com_content&task= view&id=6&Itemid=13
31. Siriwardena D., Khaw P. T., King A. J. Human antitransformig growth factor beta-2 monoclonal antibody: a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology 2002; 109:427-431. https://doi.org/10.1016/s0161-6420(01)00997-6.
32. Бакунина Н. А. Комбинированное хирургическое лечение некоторых форм рефрактерной глаукомы: автореф. … канд. мед. наук / Н. А. Бакунина. – М., 2006. – 26 с. https://www.dissercat.com/content/kombinirovannoe-khirurgi-cheskoe-lechenie-nekotorykh-form-refrakternoi-glaukomy
33. Kim J.Y., Lee JS, Lee T. Corneal endothelial cell changes and surgical results after Ahmed glaucoma valve implantation: ciliary sulcus versus anterior chamber tube placement. Sci Rep 2021; 11(1):12986. https://doi.org/10.1038/s41598-021-92420-8.
34. Christakis P.G., Zhang D., Budenz D.L, Barton K., et al. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol 2017; 176:118–126. https://doi.org/10.1016/j.ajo.2017.01.003.
35. Budenz D.L., Barton K., Feuer W.J. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011; 118:443–452. https://doi.org/10.1016/j.ophtha.2010.07.016.
36. Barton K., Feuer W.J., Budenz D.L. Three-year treatment outcomes in the Ahmed Baerveldt Comparison study. Ophthalmology 2014; 121:1547–1557. https://doi.org/10.1016/j.ophtha.2014.01.036.
37. Budenz D.L., Barton K., Gedde S.J. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 2015; 122(2):308–316. https://doi.org/10.1016/j.ophtha.2014.08.043.
38. Christakis P.G., Kalenak J.W., Zurakowski D. The Ahmed versus Baerveldt study. One-year treatment outcomes. Ophthalmology 2011; 118:2180–2189. https://doi.org/10.1016/j.ophtha.2011.05.004.
39. Christakis P.G., Tsai J.C., Kalenak J.W. The Ahmed versus Baerveldt study. Three-year treatment outcomes. Ophthalmology 2013; 120:2232–2240. https://doi.org/10.1016/j.ophtha.2013.04.018.
40. Christakis P.G., Kalenak J.W., Tsai J.C. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 2016; 123(10): 2093–2102. https://doi.org/10.1016/j.ophtha.2016.06.035.
41. Pandav S.S., Seth N.G., Thattaruthody F. Long-term outcome of lowcost glaucoma drainage device (Aurolab aqueous drainage implant) compared with Ahmed glaucoma valve. Br J Ophthalmol 2019; 104(4):557-562. https://doi.org/10.1136/bjophthalmol-2019-313942.
42. Yalvac I.S., Eksioglu U., Satana B., Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 2007; 21(1):65–70. https://doi.org/10.1038/sj.eye.6702125.
43. Topouzis F., Coleman A.L., Choplin N. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999; 128:198-204. https://doi.org/10.1016/s0002-9394(99)00080-x.
44. Ishida K., Netland P.A, Costa V.P., Shiroma L., Khan B., Ahmed I.I. Comparison of polypropylene and silicone Ahmed Glaucoma Valves. Ophthalmology 2006; 113(8):1320–1326. https://doi.org/10.1016/j.ophtha.2006.04.020.
45. Hinkle D.M., Zurakowski D., Ayyala R.S. A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve. Eur J Ophthalmol 2007; 17(5):696–701. https://doi.org/10.1177/112067210701700502.
46. Siempis T., Younus O., Makuloluwa A. Long-Term Outcomes of Ahmed Glaucoma Valve Surgery in a Scottish Cohort of Patients With Refractory Glaucoma. Cureus 2023; 15(3):358-377. https://doi.org/10.7759/cureus.35877.
47. Xie Z., Liu H., Du M., Zhu M., et al. Efficacy of Ahmed glaucoma valve implantation on neovascular glaucoma. Int J Med Sci 2019; 16:1371-1376. https://doi.org/10.7150/ijms.35267.
48. Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis). Trans Am Ophthalmol Soc 2009; 107:325-342. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814575/pdf/1545-6110_v107
49. Bowden E.C, Choudhury A., Gedde S.J., et al. Risk factors for failure of tube shunt surgery: a pooled data analysis. Am J Ophthalmol 2022; 240:217–224. https://doi.org/10.1016/j.ajo.2022.02.027.
50. Souza C., Tran D.H., Loman J., Law S.K.,et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007; 144(6):893–900. https://doi.org/10.1016/j.ajo.2007.07.035.
51. Ramji S., Nagi G., Ansari A. S., Kailani O. A systematic review and meta-analysis of randomised controlled trials in the management of neovascular glaucoma: absence of consensus and variability in practice. Graefe's Arch Clin Exp Ophthalmol 2023; 261:477–501. https://doi.org/10.1007/s00417-022-05785-5.
52. Teixeira S.H., Doi L.M., Freitas Silva A.L., et al. Silicone Ahmed glaucoma valve with and without intravitreal triamcinolone acetonide for neovascular glaucoma: randomized clinical trial. J Glaucoma 2012; 21(5):342–348. https://doi.org/10.1097/IJG.0b013e31820d7e4e.
53. Minckler D.S., Francis B.A., Hodapp E.A. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology 2008; 115:1089-1098. https://doi.org/10.1016/j.ophtha.2008.03.031.
54. Hwang H.B., Han J.W., Yim H.B. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review. J Ocul Pharmacol Ther 2015; 31(4):198–203. https://doi.org/10.1089/jop.2014.0108.
55. Arcieri E.S., Paula JS, Jorge R. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol 2015; 93(1):1–6. https://doi.org/10.1111/aos.12493.
56. Choy B., Lai J., Yeung J. Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese – a pilot study. Clin Ophthalmol 2018; 12:2545–2552. https://doi.org/10.2147/OPTH.S188999.
57. Lin P., Zhao Q., He J. Comparisons of the short- term effectiveness and safety of surgical treatment for neovascular glaucoma: a systematic review and network meta-analysis. BMJ Open 2022; 12: e051794. https://doi.org/10.1136/bmjopen-2021-051794.
58. Mahdy R.A., Nada W.M., Fawzy K.M. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. J Glaucoma 2013; 22(9):768– 772. https://doi.org/10.1097/IJG.0b013e318259aec4.
59. Zhou M., Xu X., Zhang X. Clinical outcomes of Ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: a systematic review and meta-analysis. J Glaucoma 2016; 25:551–557. https://doi.org/10.1097/IJG.0000000000000241.
60. Evans J.R., Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev – 2014: CD011234 https://doi.org/10.1002/14651858.
61. Дмитриева А.Л., Мясникова В.В., Авакимян Р.А., Хутим Т. Р. и др. Влияние ингибиторов ангиогенеза на течение послеоперационного периода при имплантации клапана Ахмеда у пациентов с неоваскулярной глаукомой. Национальный журнал глаукома 2022; 21(4):37-47. https://doi.org/10.53432/2078-4104-2022-21-4-37-47.
62. Чупров А. Д., Казеннов А. Н., Казеннова И. А. Эффективность имплантации клапана Ахмед при вторичной неоваскулярной глаукоме. Вестник Нац мед-хир центра им. Н.И. Пирогова 2022; 17(4):79-81. https://doi.org/10.25881/20728255_2022_17_4_S1_79.
63. Gandhi M., Bhartiya S. (Eds.) Glaucoma Drainage Devices: A Practical Illustrated Guide Illustrated Guide. Springer, 2019. – 171 p.
64. Chen J., Gedde SJ. New developments in tube shunt surgery. Curr Opin Ophthalmol 2019; 30:125-131. https://doi.org/10.1097/ICU.0000000000000549.
65. Maheshwari D., Rao S, Pawar N. Early outcomes of 21-gauge needleguided ab interno tube sulcus placement of a non-valved implant in pseudophakic eyes. Indian J Ophthalmol 2022; 70:1051-1053. https://doi.org/10.4103/ijo.IJO_2303_21.
66. Bayer A., Onol M. Clinical outcomes of Ahmed glaucoma valve in anterior chamber versus ciliary sulcus. Eye 2017; 31(4):608–614. https://doi.org/10.1038/eye.2016.273.
67. Nitta K., Akiyama H. A New Technique Using a 4-0 Nylon Thread as a Guide for Easy and Precise Tube Insertion of Ahmed Glaucoma Valve Implant Into Ciliary Sulcus. Cureus 2023; 11;15(2):e34854. https://doi.org/10.7759/cureus.34854.
68. Wang B., Li W. Comparison of pars plana with anterior chamber glaucoma drainage device implantation for glaucoma: a meta-analysis. BMC Ophthalmol 2018; 18(1):212. https://doi.org/10.1186/s12886-018-0896-x.
69. Kumar H., Thulasidas M. Pars plana implantation of glaucoma drainage devices- the way to succeed in refractory glaucoma. Indian J Ophthalmol 2021; 69(7):1650–1651. https://doi.org/10.4103/ijo.IJO_688_21.
70. Souza C., Tran D.H., Loman J., Law S.K., et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007; 144:893–900. https://doi.org/10.1016/j.ajo.2007.07.035.
71. Sidoti P.A., Mosny AY, Ritterband DC, Seedor JA. Pars plana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal disease. Ophthalmology 2001; 108:1050–1058. https://doi.org/10.1016/s0161-6420(01)00583-8.
72. Siegner S.W., Netland P.A., Urban R.C. Jr, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology 1995; 102:1298–1307. https://doi.org/10.1016/s0161-6420(95)30871-8.
73. Weiner A., Cohn A.D., Balasubramaniam M., et al. Glaucoma tube shunt implantation through the ciliary sulcus in pseudophakic eyes with high risk of corneal decompensation. J Glaucoma 2010; 19:405– 411. https://doi.org/10.1097/IJG.0b013e3181bdb52d.
74. Zhang, Q., Liu Y., Thanapaisal S. The effect of tube location on corneal endothelial cells in patients with Ahmed glaucoma valve. Ophthalmology 2021; 128:218–226. https://doi.org/10.1016/j.ophtha.2020.06.050.
75. Ayyala R.S., Zurakowski D., Smith J.A. A clinical study of the Ahmed glaucoma valve implant in advancedglaucoma. Ophthalmology 1998; 105:1968–1976. https://doi.org/10.1016/S0161-6420(98)91049-1.
76. Eslami Y., Mohammadi M., Fakhraie G. Ahmed glaucoma valve implantation with tube insertion through the ciliary sulcus in pseudophakic/aphakic eyes. J Glaucoma 2014; 23:115–118. https://doi.org/10.1097/IJG.0b013e318265bc0b.
77. Imamoglu S., Ercalik N. Y., Beser B. G. Ciliary Sulcus Implantation of Ahmed Valve. Beyoglu Eye J 2019; 4(2):115-119. https://doi.org/10.14744/bej.2019.00710.
78. Asaoka S., Kasuga T, Matsunaga T. Operative complications of glaucoma drainage implant tube insertion through the sulcus for pseudophakic eye. J Glaucoma 2021; 30:169-174. https://doi.org/10.1097/IJG.0000000000001783.
79. Moreno-Montañés J., Guirao-Navarro C., Argüeso F. Ab interno implantation of glaucoma drainage devices tubes in the posterior chamber. BMC Ophthalmol 2020; 20(1):66. https://doi.org/10.1186/s12886-020-1329-1.
80. Loayza-Gamboa W., Martel-Ramirez V., Inga-Condezo V. Needle guided ab interno technique for tube insertion through the ciliary sulcus in uncontrolled glaucoma. Eur J Ophthalmol 2022; 32:704-708. https://doi.org/10.1177/11206721211007093.
81. Moreno-Montañés J., Fantes F., García-Gómez P. Polypropylene sutureguided valve tube for posterior chamber implantation in patients with pseudophakic glaucoma. J Cataract Refract Surg 2008; 34(11):1828- 1831. https://doi.org/10.1016/j.jcrs.2008.05.063.
82. Tojo N., Hayashi A., Consolvo-Ueda T. Baerveldt surgery outcomes: Anterior chamber insertion versus vitreous cavity insertion. Graefes Arch Clin Exp Ophthalmol 2018; 256:2191–2200. https://doi.org/10.1007/s00417-018-4116-4.
83. Sidoti P.A., Dunphy T.R., Baerveldt G. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995; 10:1107-1118. https://doi.org/10.1016/s0161-6420(95)30904-9.
84. Tojo N., Nakamura T., Ueda T.C., Yanagisawa S., et al. Results of the Baerveldt® glaucoma implant for neovascular glaucoma patients. Nippon Ganka Gakkai Zasshi 2017; 121:138–145. https://pubmed.ncbi.nlm.nih.gov/30080004/
85. Tsoukanas D., Xanthopoulou P., Charonis A.C., Theodossiadis P., et al. Heterologous, fresh, human donor sclera as patch graft material in glaucoma drainage device surgery. J. Glaucoma 2016; 25:558–564. https://doi.org/10.1097/IJG.0000000000000294.
86. Tamcelik N., Ozkok A., Sarıcı A.M. Tenon advancement and duplication technique to prevent postoperative Ahmed valve tube exposure in patients with refractory glaucoma. Jpn J Ophthalmol 2013; 57: 359–364. https://doi.org/10.1007/s10384-013-0249-5.
87. Van Hoefen Wijsard M., Haan M., Rietveld E., van Rijn L.J. Donor sclera versus bovine pericardium as patch graft material in glaucoma implant surgery and the impact of a drainage suture. Acta Ophthalmol 2018; 96:692–698. https://doi.org/10.1111/aos.13721.
88. Tanji T.M., Lundy D.C., Minckler D.S., Heuer D.K., et al. Fascia lata patch graft in glaucoma tube surgery. Ophthalmology 1996; 103:1309–1312. https://doi.org/10.1016/s0161-6420(96)30506-x.
89. Brandt J.D. Patch grafts of dehydrated cadaveric dura mater for tubeshunt glaucoma surgery. Arch Ophthalmol 1993; 111:1436–1439. https://doi.org/10.1001/archopht.1993.01090100144042.
90. Kugu S., Erdogan G., Sevim M.S., Ozerturk, Y. Efficacy of long scleral tunnel technique in preventing Ahmed glaucoma valve tube exposure through conjunctiva. Semin Ophthalmol 2015; 30:1–5. https://doi.org/10.3109/08820538.2013.807851.
91. Singh M., Chew P.T., Tan, D. Corneal patch graft repair of exposed glaucoma drainage implants. Cornea 2008; 27:1171–1173. https://doi.org/10.1097/ICO.0b013e3181814d15.
92. Pakravan M., Hatami M., Esfandiari H., Yazdani S., et al. Ahmed glaucoma valve implantation: Graft-free short tunnel small flap versus scleral patch graft after 1-Year follow-up: A randomized clinical trial. Ophthalmol. Glaucoma 2018; 1:206–212. https://doi.org/10.1016/j.ogla.2018.10.008.
93. Ma X.H., Du X.J., Liu B., Bi H.S. Modified scleral tunnel to prevent tube exposure in patients with refractory glaucoma. J Glaucoma 2016; 25:883–885. https://doi.org/10.1097/IJG.0000000000000463.
94. Ozdamar A., Aras C., Karacorlu M. Suprachoroidal seton implantation in refractory glaucoma: A novel surgical technique. J Glaucoma 2003; 12:354–359. https://doi.org/10.1097/00061198-200308000-00010.
95. Расческов А. Ю. Способ имплантации дренажного клапана для нормализации внутриглазного давления. Патент на изобретение RUS 2434613, 17.05.2010. https://yandex.ru/patents/doc/RU2434613C1_20111127
96. Maki H., Mori S., Imai H. Autologous Scleral Pocket Technique for Ahmed Glaucoma Valve Implantation with Pars Plana Tube Insertion for Neovascular Glaucoma. J Clin Med 2021; 10:1606. https://doi.org/10.3390/jcm10081606.
97. Iwasaki K., Arimura S., Takihara Y. Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE 2018; 13:e0201342. https://doi.org/10.1371/journal.pone.0201342.
98. Mori S., Sotani N., Ueda K., Sakamoto M., et al. Three-year outcome of sulcus fixation of Baerveldt glaucoma implant surgery. Acta Ophthalmol 2021; 99(8):1435-1441. https://doi.org/10.1111/aos.14839.
99. Elbaklish K. H., Gomaa W. A. A One-Year Follow-Up of Two Ahmed Glaucoma Valve Models (S2 and FP7) for Refractory Glaucoma: A Prospective Randomized Trial. Clin Ophthalmol 2020; 14:693–705. https://doi.org/10.2147/OPTH.S224653.
100. Eibschitz-Tsimhoni M., Schertzer R.M., Musch D.C., Moroi SE. Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion. J Glaucoma 2005; 14(4):276–279. https://doi.org/10.1097/01.ijg.0000169391.94555.c1.
101. Ozalp O., Ilguy S., Atalay E., Simsek T., et al. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation. Int Ophthalmol 2022; 42(1):147–156. https://doi.org/10.1007/s10792-021-02009-3.
102. Pitukcheewanont O., Tantisevi V., Chansangpetch S., Rojanapongpun P. Factors related to hypertensive phase after glaucoma drainage device implantation. Clin Ophthalmol 2018; 12:1479–1486. https://doi.org/10.2147/OPTH.S166244.
103. Quaranta L., Floriani I., Hollander L., Poli D., et al. Needle revision with 5-fluorouracil for the treatment of Ahmed glaucoma valve filtering blebs: 5-fluorouracil needling revision can be a useful and safe tool in the management of failing Ahmed glaucoma valve filtering blebs. J Glaucoma 2016; 25(4):e367–371. https://doi.org/10.1097/IJG.0000000000000366.
104. Shah A.A., WuDunn D., Cantor L.B. Shunt revision versus additional tube shunt implantation after failed tube shunt surgery in refractory glaucoma. Am J Ophthalmol 2000; 129:455-460. https://doi.org/10.1016/s0002-9394(99)00410-9.
105. Lee S. E., Kim K. N., Kim W. J., et al. Encapsulated Bleb Excision with Collagen Matrix Implantation Following Failed Ahmed Glaucoma Valve Implantation. Korean J Ophthalmol 2019; 33(3):214-221. https://doi.org/10.3341/kjo.2018.0110.
106. Жаворонков С.А., Гурьева Н.В., Югай А.Г., Махмутов В.Ю., и др. Применение ПТФЭ мембран для профилактики фиброзирования при имплантации Ahmed дренажа при рефрактерной глаукоме. Офтальмология 2016; 13(3):151–156. https://doi.org/10.18008/1816–5095–2016-3–151–156.
107. Расческов А. Ю. Способ профилактики рубцевания фильтрационной подушки при проведении антиглаукоматозных операцией с имплантацией дренажа клапанного типа Ahmed. Заявка на патент 2022122598/14 от 27.06.2022.
108. Pham C., Radclife N. M., Vu D. M. Surgical outcomes associated with a sutureless drainage valve implantation procedure in patients with refractory glaucoma. Clin Ophthalmol 2018; 12:2607–2615. https://doi.org/10.2147/OPTH.S186369.
109. Alvarado J.A., Hollander D.A., Juster R.P., Lee L.C. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: longterm outcomes. Am J Ophthalmol 2008; 146(2):276–284. https://doi.org/10.1016/j.ajo.2008.04.008.
110. Mahdy R.A.R. Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma. J Glaucoma 2011; 20(7):458–463. https://doi.org/10.1097/IJG.0b013e3181efbea5.
111. Yazdani S., Mahboobipour H., Pakravan M., Doozandeh A., et al. Adjunctive Mitomycin C or amniotic membrane transplantation for Ahmed glaucoma valve implantation: a randomized clinical trial. J Glaucoma 2016; 25(5):415–421. https://doi.org/10.1097/IJG.0000000000000256.
112. Costa V.P., Azuara-Blanco A., Netland P.A., Lesk M.R., et al. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 2004; 111(6):1071–1076. https://doi.org/10.1016/j.ophtha.2003.09.037.
113. Al-Mobarak F., Khan A.O. Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. Ophthalmology 2009; 116(10):1862–1865. https://doi.org/10.1016/j.ophtha.2009.03.030.
114. Chaku M., Netland P.A., Ishida K., Rhee D.J. Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery. Clin Ophthalmol 2016; 10:547-553. https://doi.org/10.2147/OPTH.S104029.
115. Scott G.R., Weizer J.S., Moroi S.E., et al. Can topical ketorolac 0.5% improve the function of Ahmed_glaucoma drainage devices? Ophthalmic Surg Lasers Imaging 2011; 42:190-195. https://doi.org/10.3928/15428877-20110324-03.
116. Almatlouh A., Bach-Holm D., Kessel L. Steroids and nonsteroidal anti-inflammatory drugs in the postoperative regime after trabeculectomydwhich provides the better outcome? Asystematic review and meta-analysis. Acta Ophthalmol 2019; 97:146-157. https://doi.org/10.1111/aos.13919.
117. Kao B.W., Fong C.W., Yu Y., Ying G.S., et al. Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Postoperative Use of Prednisolone Acetate versus Difluprednate. Ophthalmol Glaucoma 2022; 5(5):468-475. https://doi.org/10.1016/j.ogla.2022.03.003.
Рецензия
Для цитирования:
Расческов А.Ю., Лоскутов И.А., Корнеева А.В. Клапанная дренажная система Ahmed в хирургии глаукомы. Национальный журнал Глаукома. 2024;23(1):96-111. https://doi.org/10.53432/2078-4104-2024-23-1-96-111
For citation:
Rascheskov A.Yu., Loskoutov I.A., Korneeva A.V. Ahmed glaucoma valve implantation in glaucoma surgery. National Journal glaucoma. 2024;23(1):96-111. (In Russ.) https://doi.org/10.53432/2078-4104-2024-23-1-96-111
Просмотров:
441
Послать статью по эл. почте 